Korean J Gastrointest Endosc.
2000 Aug;21(2):662-665.
Treatment of Pancreatic Ascites with Endoscopic Pancreatic Duct Stenting and Octreotide Injection
- Affiliations
-
- 1Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Abstract
- Pancreatic ascites is an exudative which is an amylase-rich accumulation of intraperitoneal fluid and occurs in association with rupture of a pseudocyst or disruption of the pancreatic duct. Characteristically the patient presents with increasing abdominal girth, weight loss, and varying degrees of abdominal pain. Conservative medical management, including withholding of oral feeding, total parenteral nutrition, and large volume paracentesis has led to successful resolution of pancreatic ascites in less than 50% of cases. Recently octreotide injection and endoscopic transpapillary pancreatic duct stenting have made a major impact on the conservative treatment of pancreatic ascites. We describe the case of a patient with chronic pancreatitis and pancreatic ascites who was treated by endoscopic pancreatic duct stenting and octreotide injection.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Pancreatic ascites and pleural effusion without pancreatic duct disruption treated with stenting
- Pancreaticopleural Fistula Treated by Endoscopic Pancreatic Stenting in a Patient with Recurrent Pancreatitis
- A Case of Pancreatic Ascites Controlled with Somatostatin Analogue (Octreotide)
- The Experience of Somatostatin Analogue in Various Pancreatic Diseases
- A Case of the Main Pancreatic Duct Injury Due to Blunt Abdominal Trauma Cured by Conservative Management Including Octreotide Administration
